Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

Abstract

BACKGROUND Microalbuminuria is an early predictor of diabetic nephropathy and premature cardiovascular disease. We investigated whether treatment with an angiotensin-receptor blocker (ARB) would delay or prevent the occurrence of microalbuminuria in patients with type 2 diabetes and normoalbuminuria. METHODS In a randomized, double-blind, multicenter… (More)
DOI: 10.1056/NEJMoa1007994

Topics

6 Figures and Tables

Cite this paper

@article{Haller2011OlmesartanFT, title={Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.}, author={Hermann Haller and Sadayoshi Ito and Joseph L. Izzo and Andrzej A Januszewicz and S. Katayama and Jan Menne and Albert Mimran and Ton J Rabelink and Eberhard Ritz and Lu{\'i}s Miguel Ruilope and Lars Christian Rump and Giancarlo C Viberti}, journal={The New England journal of medicine}, year={2011}, volume={364 10}, pages={907-17} }